Welcome to our dedicated page for Agilent Technologies news (Ticker: A), a resource for investors and traders seeking the latest updates and insights on Agilent Technologies stock.
Agilent Technologies Inc. reports developments across analytical and clinical laboratory technologies, including instruments, software, services and scientific expertise used by life science, diagnostics, applied, biopharmaceutical, chemical, advanced materials, clinical lab, environmental, food, forensics, academic and government customers. Company updates commonly address financial results, product launches, laboratory workflows and changes in senior legal, governance and compliance leadership.
Recent Agilent news has highlighted the BioTek Cytation 9 cell imaging multimode reader for cell-based research and high-content screening, cancer research and diagnostics workflows, and FDA-approved companion diagnostic indications for PD-L1 IHC 22C3 pharmDx, including use in identifying certain esophageal or gastroesophageal junction carcinoma patients who may be eligible for KEYTRUDA.
Agilent Technologies (A) launched the 4150 TapeStationDx system, 4200 TapeStationDx system and TapeStationDx software to bring its automated electrophoresis platform into regulated clinical NGS sample quality control workflows.
The CE-IVD-labeled systems are designed to standardize and document DNA and RNA quality control for clinical next-generation sequencing, with automated workflows to reduce manual errors and support consistent operation. The 4150 TapeStationDx targets lower-throughput labs, handling 1 to 16 samples in tube strips, while the 4200 TapeStationDx scales from 1 to 96 samples using tube strips or 96-well plates at a constant cost per sample. Both systems provide quality control results in about 1 to 2 minutes per sample. TapeStationDx software manages data acquisition, analysis, reporting and export, and includes audit trails and electronic signatures to help support compliance with regulations such as 21 CFR Part 11 and EU Annex 11.
The portfolio is available in the United States, Canada and selected European countries. Agilent reports fiscal 2025 revenue of $6.95 billion and around 18,000 employees worldwide.
TORM (TRMD, TRMD A) has increased its share capital by 132,421 Class A shares following RSU exercises. The nominal capital rose by USD 1,324.21, with new shares subscribed in cash at DKK 111.60, DKK 124.20 and DKK 179.80 per share, without pre-emption rights for existing shareholders. The new ordinary shares carry dividend and voting rights from issuance and are expected to be admitted to trading and official listing on Nasdaq Copenhagen. After the increase, total share capital is USD 1,025,536.88 divided into 102,553,688 A-shares of USD 0.01 nominal value each, with one vote per share.
Agilent Technologies (A) declared a quarterly cash dividend of 25.5 cents per share of common stock. The dividend is scheduled to be paid on October 6, 2026, to shareholders of record as of the close of business on October 28, 2026. The company states that the timing and amount of future dividends will depend on determinations by Agilent’s board of directors. In fiscal year 2025, Agilent generated $6.95 billion in revenue and employed approximately 18,000 people worldwide.
Agilent Technologies (A) declared a quarterly cash dividend of 25.5 cents per share of common stock. The dividend is scheduled to be paid on October 28, 2026 to shareholders of record as of the close of business on October 6, 2026. Future dividend timing and amounts will depend on determinations by Agilent’s board of directors. The company reports revenue of $6.95 billion for fiscal year 2025 and approximately 18,000 employees worldwide.
TORM (TRMD, TRMD A) announced the pricing of a secondary public offering of 9,000,000 Class A common shares sold by OCM Njord Holdings S.à r.l. for gross proceeds of approximately U.S. $290.25 million to the selling shareholder.
The underwriter, J.P. Morgan Securities LLC, has a 30-day option to buy up to an additional 1,350,000 shares. The company will not sell any shares and will not receive proceeds. The offering is expected to close on September 16, 2026 and is being made under an effective SEC shelf registration.
TORM plc (TRMD / TRMD A) announced a secondary public offering of 9,000,000 Class A common shares by selling shareholder OCM Njord Holdings S.à r.l., which is indirectly owned by Oaktree-managed funds. The selling shareholder plans to grant the underwriter a 30-day option to buy up to an additional 1,350,000 Class A shares. TORM is not issuing shares and will not receive proceeds. J.P. Morgan Securities LLC is sole underwriter, and the offer will be made via an effective SEC shelf registration, subject to market and other conditions.
Agilent Technologies (A) will participate in a fireside chat at the J.P. Morgan U.S. All Stars Conference at 10 a.m. BST on Sept. 23, 2026, in London.
CEO Padraig McDonnell and CFO Adam Elinoff are scheduled to speak. A live audio webcast and replay of the presentation will be available via Agilent’s Investor Relations website. The company reports revenue of $6.95 billion for fiscal year 2025 and has approximately 18,000 employees worldwide.
Agilent Technologies (A) announced the retirement of independent board chair Koh Boon Hwee, effective Sept. 4, 2026, after more than 20 years as a director.
He joined the board in 2003, became independent chair in 2017, and led the Executive Committee and the Nominating and Corporate Governance Committee. Following his retirement, the board elected Dow R. Wilson as chair, also effective Sept. 4, 2026; Wilson has served as a director since 2018 and chairs the Audit and Finance Committee. Agilent also appointed Glenn Boehnlein, former Stryker Corporation CFO, to its board on the same date. The company reports fiscal 2025 revenue of $6.95 billion and a workforce of about 18,000 employees worldwide.
Agilent Technologies (A) has launched the Agilent S540MD Slide Scanner System in the United States, a whole slide imaging digital scanner cleared by the FDA for use in digital pathology workflows.
The S540MD supports up to 540 slides, offers continuous loading and standard rack compatibility, and includes automated scanning modes with advanced tissue detection to help high-volume pathology laboratories digitize glass slides efficiently. The scanner is an Agilent-branded version of the Hamamatsu NanoZoomer S540MD system. Agilent states that this launch strengthens its digital pathology portfolio and supports laboratories facing rising sample volumes and the shift toward digital and AI-enabled workflows. The system is now available across the U.S. and in multiple European markets following an earlier launch in select European countries in January 2026.
Agilent Technologies (NYSE: A) has launched the Cary 635 FTIR spectrometer, a compact, high-performance Fourier transform infrared system designed to meet modern laboratory demands for efficiency, reliability, and space savings. The instrument features solid ZnSe optics for moisture resistance, improved sensitivity for lower-concentration samples, and a highly modular architecture that supports solids, liquids, powders, and gases.
The Cary 635 FTIR incorporates a nondynamic interferometer, permanently aligned optics for rapid module changes, and compatibility with the Agilent DialPath module to simplify liquid measurements while reducing consumables and sample volume. Method-driven MicroLab software offers guided workflows and color-coded results, enabling rapid training of users and supporting both routine and complex applications. Agilent reports fiscal 2025 revenue of $6.95 billion and a workforce of about 18,000 employees worldwide.